Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

about

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

Item

http://www.wikidata.org/entity/Q47161187

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

@en

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

@nl

type

Item

label

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

@en

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

@nl

prefLabel

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

@en

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

@nl

P1476

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

@en

P2093

Angela Maxwell-Horn

http://www.w3.org/2001/XMLSchema#string

Christiana J Bernal

http://www.w3.org/2001/XMLSchema#string

Ida Aka

http://www.w3.org/2001/XMLSchema#string

Kazeem A Oshikoya

http://www.w3.org/2001/XMLSchema#string

Robert Carroll

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

Pharmacogenomics knowledge for personalized medicine

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

CYP2D6 polymorphisms and their influence on risperidone treatment

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice

Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype

Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol

Single-dose pharmacokinetics of oral and intravenous pantoprazole in children and adolescents.

P31

scholarly article

P356

10.3390/JPM7040014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sara L. Van Driest

P577

2017-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29099060

http://www.w3.org/2001/XMLSchema#string

P932

5748626

http://www.w3.org/2001/XMLSchema#string